CVS Group (LON:CVSG) Shares Up 1.2% – Here’s Why

Posted by Stanley Muller on Nov 10th, 2026

CVS Group plc (LON:CVSG – Get Free Report) shot up 1.2% during trading on Monday. The stock traded as high as GBX 1,379 and last traded at GBX 1,370. 389,990 shares changed hands during trading, a decline of 55% from the average daily volume of 867,277 shares. The stock had previously closed at GBX 1,354.25.

Analyst Upgrades and Downgrades

CVSG has been the subject of a number of analyst reports. Jefferies Financial Group restated a “hold” rating and issued a GBX 1,400 price target on shares of CVS Group in a research note on Friday, September 25th. Berenberg Bank reiterated a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday, September 24th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,700 price objective on shares of CVS Group in a report on Monday, July 27th. Finally, Shore Capital Group reissued a “hold” rating and issued a GBX 1,400 target price on shares of CVS Group in a research note on Thursday, September 24th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of GBX 1,666.67.

Get Our Latest Stock Report on CVSG

CVS Group Stock Up 1.2%

The company has a current ratio of 1.18, a quick ratio of 0.90 and a debt-to-equity ratio of 110.41. The firm’s 50 day moving average price is GBX 1,277.01 and its two-hundred day moving average price is GBX 1,254.24. The company has a market capitalization of £913.72 million, a price-to-earnings ratio of 56.38, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07.

CVS Group (LON:CVSG – Get Free Report) last issued its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. Sell-side analysts anticipate that CVS Group plc will post 93.94 earnings per share for the current fiscal year.

CVS Group Company Profile

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.